PF-06751979 multiple ascending dose

DRUG2 trials

Sponsors

Pfizer

Conditions

Healthy Subjects

Phase 1

First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

CompletedNCT02509117

PfizerHealthy Subjects

Start: 2015-07-31End: 2016-07-31Updated: 2018-11-01

Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.

CompletedNCT02793232

PfizerHealthy Subjects

Start: 2016-06-13End: 2017-01-05Updated: 2018-09-17

Related Papers

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older Subjects

Journal of Alzheimer s Disease2019-08-1624 citations